LeMaitre Vascular Inc (LeMaitre Vascular), provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vascular surgeries and minimally invasive procedures. Its product portfolio includes polycarbonate grafts, balloon catheters, carotid shunts, radiopaque tapes, powered phlebectomy devices, valvulotomes, remote endarterectomy devices, vascular grafts, patches, contrast injector, ePTFE grafts and closure systems. It also offers angioscopes and human tissue cryopreservation services. LeMaitre Vascular sells its products through direct sales force and subsidiaries in North America, Europe, Asia-Pacific and through distributors in other geographies. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company LeMaitre Vascular Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- LeMaitre Vascular Inc Company Overview
- LeMaitre Vascular Inc Company Snapshot
- LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview
- LeMaitre Vascular Inc - Pipeline Analysis Overview
- Business Description
- LeMaitre Vascular Inc - Key Facts
- LeMaitre Vascular Inc - Major Products and Services
- LeMaitre Vascular Inc Pipeline Products by Development Stage
- LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
- LeMaitre Vascular Inc Pipeline Products Overview
- ADAPT - Hernia Repair
- ADAPT - Hernia Repair Product Overview
- CardioCel
- CardioCel Product Overview
- CardioCel Clinical Trial
- Cardiocel - Mitral Valve Repair
- Cardiocel - Mitral Valve Repair Product Overview
- Cardiocel - Tri-Leaflet Aortic Valve Repair
- Cardiocel - Tri-Leaflet Aortic Valve Repair Product Overview
- CardioCel 3D Stage 1 Arch
- CardioCel 3D Stage 1 Arch Product Overview
- CardioCel Neo
- CardioCel Neo Product Overview
- CardioCel Neo Clinical Trial
- DuraSure
- DuraSure Product Overview
- Elongated AnastoClip AC
- Elongated AnastoClip AC Product Overview
- Elongated AnastoClip GC
- Elongated AnastoClip GC Product Overview
- LeMaitre OTW Embolectomy Catheter
- LeMaitre OTW Embolectomy Catheter Product Overview
- LeMaitre OTW Embolectomy Catheter Clinical Trial
- LeMaitre Valvulotome
- LeMaitre Valvulotome Product Overview
- NovaSil
- NovaSil Product Overview
- PIOC Occlusion Catheter
- PIOC Occlusion Catheter Product Overview
- Syntel RT Embolectomy Catheter
- Syntel RT Embolectomy Catheter Product Overview
- VascuCel
- VascuCel Product Overview
- XenoSure Biologic Vascular Patch
- XenoSure Biologic Vascular Patch Product Overview
- XenoSure Biologic Vascular Patch Clinical Trial
- LeMaitre Vascular Inc - Key Competitors
- LeMaitre Vascular Inc - Key Employees
- LeMaitre Vascular Inc - Key Employee Biographies
- LeMaitre Vascular Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- LeMaitre Vascular Inc, Recent Developments
- May 02, 2023: LeMaitre Q1 2023 financial results
- Feb 23, 2023: LeMaitre Q4 2022 Financial Results
- Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
- Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
- Jul 28, 2022: LeMaitre Q2 2022 Financial Results
- Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
- Apr 28, 2022: LeMaitre Q1 2022 Financial Results
- Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
- Feb 24, 2022: LeMaitre Q4 2021 Financial Results
- Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview
- LeMaitre Vascular Inc Pipeline Products by Equipment Type
- LeMaitre Vascular Inc Pipeline Products by Indication
- LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
- LeMaitre Vascular Inc, Key Facts
- LeMaitre Vascular Inc, Major Products and Services
- LeMaitre Vascular Inc Number of Pipeline Products by Development Stage
- LeMaitre Vascular Inc Pipeline Products Summary by Development Stage
- LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
- LeMaitre Vascular Inc Ongoing Clinical Trials Summary
- ADAPT - Hernia Repair - Product Status
- ADAPT - Hernia Repair - Product Description
- CardioCel - Product Status
- CardioCel - Product Description
- CardioCel - Efficacy and Safety of the Company’s Proprietary Bio-Scaffold Implanted to Repair Congenital Heart Disease Defects
- CardioCel - Evaluation of Outcomes Following Tricuspid Valve Cylinder Reconstruction with CardioCel in Isolated Severe Tricuspid Regurgitation
- CardioCel - Phase II Extension Study for the Repair of Congenital Heart Defects in Paediatrics Using
- CardioCel
- CardioCel - Post-market Registry in Europe for the Use of CardioCel, CardioCel Neo and CardioCel 3D
- Cardiocel - Mitral Valve Repair - Product Status
- Cardiocel - Mitral Valve Repair - Product Description
- Cardiocel - Tri-Leaflet Aortic Valve Repair - Product Status
- Cardiocel - Tri-Leaflet Aortic Valve Repair - Product Description
- CardioCel 3D Stage 1 Arch - Product Status
- CardioCel 3D Stage 1 Arch - Product Description
- CardioCel Neo - Product Status
- CardioCel Neo - Product Description
- CardioCel Neo - Post-market Registry in Europe for the Use of CardioCel, CardioCel Neo and CardioCel 3D
- DuraSure - Product Status
- DuraSure - Product Description
- Elongated AnastoClip AC - Product Status
- Elongated AnastoClip AC - Product Description
- Elongated AnastoClip GC - Product Status
- Elongated AnastoClip GC - Product Description
- LeMaitre OTW Embolectomy Catheter - Product Status
- LeMaitre OTW Embolectomy Catheter - Product Description
- LeMaitre OTW Embolectomy Catheter - A Post-market Clinical Study to Confirm the Performance and Safety of the LeMaitre TufTex Over-the-Wire (OTW) Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and/or Thrombi
- LeMaitre Valvulotome - Product Status
- LeMaitre Valvulotome - Product Description
- NovaSil - Product Status
- NovaSil - Product Description
- PIOC Occlusion Catheter - Product Status
- PIOC Occlusion Catheter - Product Description
- Syntel RT Embolectomy Catheter - Product Status
- Syntel RT Embolectomy Catheter - Product Description
- VascuCel - Product Status
- VascuCel - Product Description
- XenoSure Biologic Vascular Patch - Product Status
- XenoSure Biologic Vascular Patch - Product Description
- XenoSure Biologic Vascular Patch - Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair
- XenoSure Biologic Vascular Patch - Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Peripheral Vascular Repair
- LeMaitre Vascular Inc, Key Employees
- LeMaitre Vascular Inc, Key Employee Biographies
- LeMaitre Vascular Inc, Other Locations
- LeMaitre Vascular Inc, Subsidiaries
- Glossary
- LeMaitre Vascular Inc Pipeline Products by Equipment Type
- LeMaitre Vascular Inc Pipeline Products by Development Stage
- LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Artivion Inc
- Boston Scientific Corp
- Cardiovascular Systems Inc
- Edwards Lifesciences Corp
- Getinge AB
- LifeNet Health Inc
- Medtronic Vascular Inc
- Terumo Medical Corp
- W. L. Gore & Associates Inc
